Hexembio
hexemb.io
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$25.9M
2 rounds on record
Latest round
$15.5M
Venture round · Sep 2026 · this month
Team
11-50
employees, estimated range
Backers
2
Draper Associates, Seraphim Space
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 22
Raised a round Venture round $15.5M · CHOSUNBIZ
Apr 7
Raised a round Venture round $10.4M · led by Draper Associates · TNW Health-tech
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | $15.5M | — | CHOSUNBIZ |
| Venture round | Apr 2026 | $10.4M | Draper Associates lead, Robert Langer | TNW Health-tech |
Backed byfrom the funds' portfolios and accelerator catalogs
Draper Associates 
Seraphim Space Similar startupsby what they do, their industry and backers
Future Mobile. Press Developers Privacy Policy.
It's time to make two-wheelers safer than cars.. Privacy Policy.
Diode. DIODE © 2026, All Rights Reserved | Terms | Privacy Policy.
Select your experience - solutions for: Enterprise solutions for retail and wholesale including dealerships, auctions, inspections…
Astonished? Contact Us Email [email protected] full name* email address* message* Thank you for submitting the form.
Hushmesh is SOC 2 compliant Our Security Practices All rights reserved — Copyright 2026 Terms and Conditions - Privacy Policy.
News
HexemBio raises $15.5M as it targets aging via blood stem cell rejuvenation
HexemBio raises $15.5M as it targets aging via blood stem cell rejuvenation Young cues for old blood: HexemBio readies stem cell reboot with 2027 clin
Read more
Report
HexemBio: $10.4 Million Raised For Blood Stem Cell Rejuvenation Therapy Development
HexemBio, a biotechnology company focused on regenerative medicine, has emerged from stealth with $10.4 million in seed funding to advance a novel blood stem cell rejuvenation therapy. The round was led by Draper Associates with participation from SOSV, S
Read more
Report
HexemBio raises $10.4M for a stem cell rejuvenation therapy
HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.
Read more
Report
Report
Modelling post-implantation human development to yolk sac blood emergence
Implantation of the human embryo begins a critical developmental stage that comprises profound events including axis formation, gastrulation and the emergence of haematopoietic system1,2. Our mechanistic knowledge of this window of human life remains limi
Read more
Report